• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Mesoblast Ltd

+ Add to Watchlist

MBLTY:US

17.8500 USD 0.1100 0.61%

As of 17:10:01 ET on 12/24/2014.

Snapshot for Mesoblast Ltd (MBLTY)

Open: 17.2900 Day's Range: 17.2900 - 17.8500 Volume: 2,500
Previous Close: 17.9600 52wk Range: 16.2000 - 27.4060 1-Yr Rtn: -31.11%

Stock Chart for MBLTY

No chart data available.
  • MBLTY:US 17.8500
  • 1D
  • 1M
  • 1Y
17.9600
Interactive MBLTY Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MBLTY

Current P/E Ratio (ttm) -
Estimated P/E(06/2015) -
Relative P/E vs. SPX -
Earnings Per Share (AUD) (ttm) -
Est. EPS (AUD) (06/2015) -1.4270
Est. PEG Ratio -
Market Cap (M USD) 1,157.31
Shares Outstanding (M) 64.84
30 Day Average Volume 2,460
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/26/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MBLTY

  • Revenue
  • Net Income (M/AUD)
  • Profit Margin (%)

Company Profile & Key Executives for MBLTY

Mesoblast Ltd., is a biotechnology company. The Company develops treatments for orthopaedic conditions, including the commercialisation of adult stem cells to regenerate, repair bone. and cartilage.

Silviu ItescuChief Executive OfficerPaul HodgkinsonChief Financial Officer
James T Ryaby "Jim"VP:Research & Clinical AffairsJohn McMannisExec VP:Manufacturing
More Company Profile & Key Executives for MBLTY

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil